These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20502032)

  • 41. Antibodies to alpha-fodrin derived peptide in Sjögren's syndrome.
    He J; Chen QL; Li ZG
    Ann Rheum Dis; 2006 Apr; 65(4):549-50. PubMed ID: 16531552
    [No Abstract]   [Full Text] [Related]  

  • 42. Anti-{alpha}-fodrin autoantibodies are not useful diagnostic markers of primary Sjögren's syndrome.
    Sordet C; Gottenberg JE; Goetz J; Bengoufa D; Humbel RL; Mariette X; Sibilia J
    Ann Rheum Dis; 2005 Aug; 64(8):1244-5. PubMed ID: 16014693
    [No Abstract]   [Full Text] [Related]  

  • 43. The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.
    Beckman KA; Luchs J; Milner MS; Ambrus JL
    Adv Ther; 2017 Apr; 34(4):799-812. PubMed ID: 28283891
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjögren's syndrome.
    Toker E; Yavuz S; Direskeneli H
    Br J Ophthalmol; 2004 Mar; 88(3):384-7. PubMed ID: 14977774
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of IgG anti-{alpha}-fodrin antibodies in Sjogren's syndrome.
    Ruiz-Tíscar JL; López-Longo FJ; Sánchez-Ramón S; Santamaría B; Urrea R; Carreño L; Estecha A; Vigil D; Fernández-Cruz E; Rodríguez-Mahou M
    Ann N Y Acad Sci; 2005 Jun; 1050():210-6. PubMed ID: 16014536
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and immunological characteristics of patients with Sjögren's syndrome in relation to alpha-fodrin antibodies.
    Willeke P; Gaubitz M; Schotte H; Becker H; Mickholz E; Domschke W; Schlüter B
    Rheumatology (Oxford); 2007 Mar; 46(3):479-83. PubMed ID: 16935916
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mucosal administration of alpha-fodrin inhibits experimental Sjögren's syndrome autoimmunity.
    He J; Zhao J; Li Z
    Arthritis Res Ther; 2008; 10(2):R44. PubMed ID: 18419828
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Urban legends series: Sjögren's syndrome.
    Aframian DJ; Konttinen YT; Carrozzo M; Tzioufas AG
    Oral Dis; 2013 Jan; 19(1):46-58. PubMed ID: 22490059
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Diagnostic value of anti-alpha-fodrin antibody testing for Sjögren's syndrome: a meta-analysis].
    Huang QS; LE AP; Luo ZQ; Li JM; Wang WQ; Ju BH; Wan LG
    Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(42):2971-6. PubMed ID: 19080074
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Possible involvement of EBV-mediated alpha-fodrin cleavage for organ-specific autoantigen in Sjogren's syndrome.
    Inoue H; Tsubota K; Ono M; Kizu Y; Mizuno F; Takada K; Yamada K; Yanagi K; Hayashi Y; Saito I
    J Immunol; 2001 May; 166(9):5801-9. PubMed ID: 11313424
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of novel Sjogren's syndrome autoantibodies in patients with dry eyes.
    Everett S; Vishwanath S; Cavero V; Shen L; Suresh L; Malyavantham K; Lincoff-Cohen N; Ambrus JL
    BMC Ophthalmol; 2017 Mar; 17(1):20. PubMed ID: 28270126
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome.
    Haneji N; Nakamura T; Takio K; Yanagi K; Higashiyama H; Saito I; Noji S; Sugino H; Hayashi Y
    Science; 1997 Apr; 276(5312):604-7. PubMed ID: 9110981
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibodies against alpha-fodrin are associated with dry eyes and mouth in the general population.
    Witte T; Bierwirth J; Schmidt RE; Matthias T
    J Rheumatol; 2006 Aug; 33(8):1713. PubMed ID: 16881136
    [No Abstract]   [Full Text] [Related]  

  • 54. Anti-SSA Ro52/Ro60 antibody testing by immunodot could help the diagnosis of Sjogren's syndrome in the absence of anti-SSA/SSB antibodies by ELISA.
    Mekinian A; Nicaise-Roland P; Chollet-Martin S; Fain O; Crestani B
    Rheumatology (Oxford); 2013 Dec; 52(12):2223-8. PubMed ID: 24026249
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of autoimmune arthritis with aging via bystander T cell activation in the mouse model of Sjögren's syndrome.
    Kobayashi M; Yasui N; Ishimaru N; Arakaki R; Hayashi Y
    Arthritis Rheum; 2004 Dec; 50(12):3974-84. PubMed ID: 15593201
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alpha-fodrin as a putative autoantigen in Graves' ophthalmopathy.
    Kahaly GJ; Bang H; Berg W; Dittmar M
    Clin Exp Immunol; 2005 Apr; 140(1):166-72. PubMed ID: 15762888
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comprehensive review of autoantibodies in primary Sjögren's syndrome: clinical phenotypes and regulatory mechanisms.
    Kyriakidis NC; Kapsogeorgou EK; Tzioufas AG
    J Autoimmun; 2014 Jun; 51():67-74. PubMed ID: 24333103
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sjögren's syndrome--study of autoantigens and autoantibodies.
    Routsias JG; Tzioufas AG
    Clin Rev Allergy Immunol; 2007 Jun; 32(3):238-51. PubMed ID: 17992591
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?
    Manthorpe R; Benoni C; Jacobsson L; Kirtava Z; Larsson A; Liedholm R; Nyhagen C; Tabery H; Theander E
    Ann Rheum Dis; 2000 Jan; 59(1):54-60. PubMed ID: 10627428
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
    Jonsson R; Vogelsang P; Volchenkov R; Espinosa A; Wahren-Herlenius M; Appel S
    Immunol Lett; 2011 Dec; 141(1):1-9. PubMed ID: 21777618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.